Cambrex Expands Biopharmaceutical Services Business
- Written by PR Newswire Asia - Daily Bulletin Au RSS
![]() |
EAST RUTHERFORD, N.J., March 1, 2022 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced it is significantly expanding its existing biopharmaceutical testing services business. The...
Read more: Cambrex Expands Biopharmaceutical Services Business






